vs

Side-by-side financial comparison of CUMBERLAND PHARMACEUTICALS INC (CPIX) and enCore Energy Corp. (EU). Click either name above to swap in a different company.

CUMBERLAND PHARMACEUTICALS INC is the larger business by last-quarter revenue ($13.7M vs $12.4M, roughly 1.1× enCore Energy Corp.). CUMBERLAND PHARMACEUTICALS INC runs the higher net margin — -10.3% vs -173.9%, a 163.6% gap on every dollar of revenue. enCore Energy Corp. produced more free cash flow last quarter ($7.2M vs $3.0K).

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company that develops, manufactures and commercializes branded prescription medicines. Its core product portfolio covers acute care, gastroenterology, pain management and rare disease treatment, with its primary operating market being the United States, serving healthcare providers and patients in relevant care segments.

Devon Energy Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware with operational headquarters in the 50-story Devon Energy Center in Oklahoma City, Oklahoma. Its operations are in the Delaware Basin, Eagle Ford Group, and the Rocky Mountains.

CPIX vs EU — Head-to-Head

Bigger by revenue
CPIX
CPIX
1.1× larger
CPIX
$13.7M
$12.4M
EU
Higher net margin
CPIX
CPIX
163.6% more per $
CPIX
-10.3%
-173.9%
EU
More free cash flow
EU
EU
$7.1M more FCF
EU
$7.2M
$3.0K
CPIX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CPIX
CPIX
EU
EU
Revenue
$13.7M
$12.4M
Net Profit
$-1.4M
$-21.5M
Gross Margin
83.6%
37.9%
Operating Margin
-10.0%
-135.9%
Net Margin
-10.3%
-173.9%
Revenue YoY
31.1%
Net Profit YoY
25.8%
EPS (diluted)
$-0.09
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPIX
CPIX
EU
EU
Q4 25
$13.7M
$12.4M
Q3 25
$8.3M
$8.9M
Q2 25
$10.8M
$3.7M
Q1 25
$11.7M
$18.2M
Q4 24
$10.4M
Q3 24
$9.1M
Q2 24
$9.8M
Q1 24
$8.5M
Net Profit
CPIX
CPIX
EU
EU
Q4 25
$-1.4M
$-21.5M
Q3 25
$-1.9M
$-4.8M
Q2 25
$-740.7K
$-6.3M
Q1 25
$1.3M
$-24.2M
Q4 24
$-1.9M
Q3 24
$-1.5M
Q2 24
$-1.1M
Q1 24
$-1.9M
Gross Margin
CPIX
CPIX
EU
EU
Q4 25
83.6%
37.9%
Q3 25
88.1%
43.8%
Q2 25
81.4%
30.8%
Q1 25
87.8%
-0.1%
Q4 24
81.1%
Q3 24
85.4%
Q2 24
82.6%
Q1 24
81.5%
Operating Margin
CPIX
CPIX
EU
EU
Q4 25
-10.0%
-135.9%
Q3 25
-23.7%
-158.2%
Q2 25
-6.9%
-526.1%
Q1 25
11.0%
-85.7%
Q4 24
-17.7%
Q3 24
-18.6%
Q2 24
-10.4%
Q1 24
-22.0%
Net Margin
CPIX
CPIX
EU
EU
Q4 25
-10.3%
-173.9%
Q3 25
-23.4%
-53.7%
Q2 25
-6.8%
-172.7%
Q1 25
10.7%
-132.9%
Q4 24
-18.2%
Q3 24
-17.0%
Q2 24
-11.0%
Q1 24
-22.9%
EPS (diluted)
CPIX
CPIX
EU
EU
Q4 25
$-0.09
$-0.11
Q3 25
$-0.13
$-0.03
Q2 25
$-0.05
$-0.03
Q1 25
$0.08
$-0.13
Q4 24
$-0.13
Q3 24
$-0.11
Q2 24
$-0.08
Q1 24
$-0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPIX
CPIX
EU
EU
Cash + ST InvestmentsLiquidity on hand
$11.4M
$52.4M
Total DebtLower is stronger
$110.0M
Stockholders' EquityBook value
$24.9M
$229.2M
Total Assets
$76.8M
$430.4M
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPIX
CPIX
EU
EU
Q4 25
$11.4M
$52.4M
Q3 25
$15.2M
$91.9M
Q2 25
$16.1M
$26.9M
Q1 25
$15.1M
$29.7M
Q4 24
$18.0M
Q3 24
$17.5M
Q2 24
$17.3M
Q1 24
$18.5M
Total Debt
CPIX
CPIX
EU
EU
Q4 25
$110.0M
Q3 25
$109.3M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CPIX
CPIX
EU
EU
Q4 25
$24.9M
$229.2M
Q3 25
$26.1M
$248.6M
Q2 25
$28.0M
$264.7M
Q1 25
$28.7M
$267.9M
Q4 24
$22.9M
Q3 24
$24.8M
Q2 24
$26.3M
Q1 24
$27.5M
Total Assets
CPIX
CPIX
EU
EU
Q4 25
$76.8M
$430.4M
Q3 25
$65.9M
$441.9M
Q2 25
$67.9M
$359.4M
Q1 25
$69.9M
$362.6M
Q4 24
$75.6M
Q3 24
$76.7M
Q2 24
$78.5M
Q1 24
$81.5M
Debt / Equity
CPIX
CPIX
EU
EU
Q4 25
0.48×
Q3 25
0.44×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPIX
CPIX
EU
EU
Operating Cash FlowLast quarter
$3.0K
$12.9M
Free Cash FlowOCF − Capex
$3.0K
$7.2M
FCF MarginFCF / Revenue
0.0%
57.8%
Capex IntensityCapex / Revenue
0.0%
46.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$4.8M
$-45.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPIX
CPIX
EU
EU
Q4 25
$3.0K
$12.9M
Q3 25
$187.2K
$-20.3M
Q2 25
$843.8K
$-9.9M
Q1 25
$3.9M
$-7.7M
Q4 24
$1.9M
Q3 24
$475.5K
Q2 24
$-855.7K
Q1 24
$-2.1M
Free Cash Flow
CPIX
CPIX
EU
EU
Q4 25
$3.0K
$7.2M
Q3 25
$163.4K
$-26.3M
Q2 25
$817.3K
$-14.1M
Q1 25
$3.9M
$-11.7M
Q4 24
$1.9M
Q3 24
$460.1K
Q2 24
$-862.8K
Q1 24
$-2.2M
FCF Margin
CPIX
CPIX
EU
EU
Q4 25
0.0%
57.8%
Q3 25
2.0%
-296.6%
Q2 25
7.5%
-385.2%
Q1 25
32.9%
-64.1%
Q4 24
18.2%
Q3 24
5.1%
Q2 24
-8.8%
Q1 24
-25.6%
Capex Intensity
CPIX
CPIX
EU
EU
Q4 25
0.0%
46.7%
Q3 25
0.3%
68.0%
Q2 25
0.2%
115.1%
Q1 25
0.4%
21.7%
Q4 24
0.0%
Q3 24
0.2%
Q2 24
0.1%
Q1 24
0.5%
Cash Conversion
CPIX
CPIX
EU
EU
Q4 25
Q3 25
Q2 25
Q1 25
3.10×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons